Status:
ACTIVE_NOT_RECRUITING
Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI
Lead Sponsor:
Başakşehir Çam & Sakura City Hospital
Collaborating Sponsors:
Ankara Etlik City Hospital
Antalya City Hospital
Conditions:
Myocardial Infarction
Myocardial Ischemia
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The investigators hypothesize that occlusion myocardial infarction(MI)/non-occlusion MI approach to MI treatment will better predict acute coronary occlusion on coronary angiography, better limit infa...
Detailed Description
I. BACKGROUND AND SIGNIFICANCE The patients with acute coronary occlusion (ACO) or potentially imminent occlusion, with insufficient collateral circulation, have myocardium that is at risk of infarct...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Age \>18 years
- ECG and/or clinical diagnosis of acute myocardial infarction
- Exclusion criteria
- Active pregnancy or a suspicion of pregnancy
- Rejection or withdrawal of consent
- Failure to acquire any of the pre-participation ECGs
- Non-ischemic myocardial injury
- Application of thrombolytic therapy instead of primary PCI
- Re-occlusion of the culprit lesion after intervention\*
- New vessel occlusion during hospital stay\*
- Exclusion from final analyses.
Exclusion
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2026
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT06570759
Start Date
October 1 2024
End Date
September 1 2026
Last Update
September 3 2025
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Etlik City Hospital
Ankara, Turkey (Türkiye), 6010
2
Antalya City Hospital
Antalya, Turkey (Türkiye), 07080
3
Erzurum Atatürk University Hospital
Erzurum, Turkey (Türkiye), 25040
4
Eskisehir Osmangazi University Hospital
Eskişehir, Turkey (Türkiye), 26040